🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| 14/12/2022 | 0,7300 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/07/2016 | 57,13 | 57,19 | 56,76 | 56,92 | +0,17% | 0,75% | 7.698.084 |
| 13/07/2016 | 57,04 | 57,20 | 56,76 | 56,82 | -0,08% | 0,79% | 7.119.274 |
| 12/07/2016 | 56,56 | 57,05 | 56,37 | 56,87 | +0,44% | 1,20% | 8.804.562 |
| 11/07/2016 | 56,55 | 57,01 | 56,49 | 56,62 | -0,02% | 0,93% | 7.688.862 |
| 08/07/2016 | 56,28 | 56,84 | 56,11 | 56,63 | +0,97% | 1,31% | 9.934.411 |
| 07/07/2016 | 56,19 | 56,32 | 55,62 | 56,09 | -0,64% | 1,24% | 9.800.791 |
| 06/07/2016 | 55,60 | 56,56 | 55,41 | 56,45 | +2,00% | 2,06% | 15.015.430 |
| 05/07/2016 | 55,13 | 55,51 | 55,13 | 55,34 | +0,10% | 0,67% | 7.749.017 |
| 01/07/2016 | 54,90 | 55,34 | 54,79 | 55,29 | +0,57% | 1,01% | 8.245.978 |
| 30/06/2016 | 54,53 | 55,04 | 54,30 | 54,97 | +0,98% | 1,35% | 9.723.030 |
| 29/06/2016 | 53,57 | 54,52 | 53,42 | 54,44 | +2,64% | 2,07% | 10.284.862 |
| 28/06/2016 | 52,90 | 53,12 | 52,59 | 53,03 | +0,49% | 1,01% | 13.372.585 |
| 27/06/2016 | 52,95 | 53,13 | 52,58 | 52,78 | -1,02% | 1,05% | 13.721.778 |
| 24/06/2016 | 53,47 | 54,46 | 53,22 | 53,32 | -3,12% | 2,32% | 18.087.013 |
| 23/06/2016 | 54,85 | 55,04 | 54,49 | 55,04 | +1,12% | 0,99% | 7.302.883 |
| 22/06/2016 | 53,57 | 54,65 | 53,53 | 54,43 | +1,40% | 2,08% | 13.076.420 |
| 21/06/2016 | 53,95 | 54,07 | 53,66 | 53,67 | +0,20% | 0,76% | 6.710.344 |
| 20/06/2016 | 53,76 | 54,01 | 53,55 | 53,57 | +0,45% | 0,85% | 9.116.238 |
| 17/06/2016 | 54,80 | 54,80 | 53,15 | 53,33 | -2,80% | 3,01% | 18.323.651 |
| 16/06/2016 | 54,38 | 55,03 | 53,56 | 54,87 | +2,51% | 2,70% | 23.110.706 |
| 15/06/2016 | 53,83 | 53,93 | 53,39 | 53,52 | -0,28% | 1,01% | 8.015.942 |
| 14/06/2016 | 53,22 | 53,73 | 53,07 | 53,67 | +0,25% | 1,24% | 9.006.722 |
| 13/06/2016 | 53,61 | 54,08 | 53,52 | 53,54 | -1,23% | 1,05% | 6.502.630 |
| 10/06/2016 | 54,22 | 54,47 | 53,98 | 54,21 | -0,65% | 0,90% | 9.989.222 |
| 09/06/2016 | 54,88 | 55,17 | 54,32 | 54,56 | -0,76% | 1,55% | 9.670.630 |
| 08/06/2016 | 54,36 | 55,22 | 54,36 | 54,98 | +1,09% | 1,58% | 8.164.025 |
| 07/06/2016 | 54,58 | 54,81 | 54,31 | 54,39 | -0,30% | 0,91% | 6.552.515 |
| 06/06/2016 | 54,06 | 54,74 | 54,06 | 54,55 | +0,94% | 1,27% | 7.235.392 |
| 03/06/2016 | 54,24 | 54,35 | 53,70 | 54,05 | -0,32% | 1,20% | 5.697.871 |
| 02/06/2016 | 53,86 | 54,26 | 53,78 | 54,22 | +0,87% | 0,89% | 7.645.684 |